Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2024-11-11 Regulatory Filings
Country TW Taiwan
Listing TW 1720

About S.C.P.C

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
公告本公司召開法人說明會相關資訊
Regulatory Filings Classification · 95% confidence The document is a short announcement (670 characters) from a company (1720 生達) about the scheduling of a '法人說明會' (investor presentation or analyst meeting) to be held on 113/11/14. It provides details such as date, time, location, and a brief summary that the meeting will cover the operational overview for the first three quarters of 2024. It also directs readers to the official information site for complete financial and business information. There is no actual financial data or detailed report content included in this document. The document is clearly an announcement about an upcoming investor presentation event, not the presentation or report itself. According to the MENU VS MEAL RULE, this is an announcement of a presentation, so it should be classified as Investor Presentation (IP). However, since it only announces the event and does not contain the presentation materials, it fits better as a Regulatory Filing (RNS) or Report Publication Announcement (RPA). But RPA is for announcements about report publication, not event scheduling. Therefore, the best fit is Regulatory Filings (RNS) as a general announcement about the event. Confidence is high due to clear event announcement nature and lack of actual report content.
2024-11-11 Chinese
113年第3季財務報告書 — 202404_1720_AIC.pdf
Audit Report / Information Classification · 100% confidence The document is titled 'INDEPENDENT AUDITORS’ REPORT' for STANDARD CHEM. & PHARM. CO., LTD. covering the parent company only financial statements for the years ended December 31, 2024 and 2023. It includes an auditor's opinion, basis for opinion, key audit matters, responsibilities of management and auditors, and detailed financial statements such as balance sheets. The content is consistent with a standalone audit report rather than a full annual report or other filing types. The document length is substantial (15,000 characters), indicating it is the full audit report, not just an announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR).
2024-11-11 Chinese
113年第3季財務報告書 — 202404_1720_AIA.pdf
Audit Report / Information Classification · 95% confidence The document is titled 'CONSOLIDATED FINANCIAL STATEMENTS AND INDEPENDENT AUDITORS’ REPORT DECEMBER 31, 2024 AND 2023' and contains detailed consolidated financial statements, an independent auditor's report, audit opinion, key audit matters, and extensive financial data for the years ended December 31, 2024 and 2023. It includes comprehensive financial information such as balance sheets, income statements, cash flows, notes to the financial statements, and auditor's responsibilities. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or certification. The presence of the independent auditor's report and full consolidated financial statements aligns with the definition of an Audit Report / Information filing, which includes standalone audit reports and applied accounting principles, excluding full annual reports. There is no indication that this is a full Annual Report (10-K) as it lacks broader management discussion, business overview, and other annual report components. Therefore, the document fits best under the Audit Report / Information (AR) category.
2024-11-11 Chinese
113年第3季財務報告書 — 202404_1720_AI3.pdf
Audit Report / Information Classification · 100% confidence The document is titled as "個體財務報告暨會計師查核報告" which translates to "Individual Financial Report and Auditor's Report" for the fiscal years 112 and 113 (corresponding to 2023 and 2024). It contains detailed financial statements such as the balance sheet, income statement, statement of changes in equity, cash flow statement, and notes to the financial statements. It also includes the auditor's opinion and key audit matters, which are typical components of an audit report. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of the auditor's report and detailed financial data confirms this is a standalone audit report rather than a full annual report (10-K) or an interim report. Therefore, the document fits the category of Audit Report / Information (AR).
2024-11-11 Chinese
113年第3季財務報告書 — 202404_1720_AI1.pdf
Annual Report Classification · 100% confidence The document is titled as a consolidated financial report and auditor's report for the fiscal years 113 and 112 (Taiwanese calendar years, corresponding to 2024 and 2023). It includes detailed consolidated financial statements such as the balance sheet, income statement, statement of changes in equity, and cash flow statement, along with extensive notes and an auditor's opinion. The presence of an auditor's report integrated with the financial statements and detailed financial data confirms this is a full annual report. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, the document fits the definition of an Annual Report (10-K).
2024-11-11 Chinese
113年第3季財務報告書 — 202403_1720_AI1.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "合併財務報告暨會計師核閱報告" which translates to "Consolidated Financial Report and Accountant's Review Report". It covers the third quarter of the fiscal years 113 and 112 (which correspond to 2024 and 2023 in the Gregorian calendar). The content includes consolidated balance sheets, income statements, cash flow statements, equity changes, and detailed notes. It also contains an accountant's review report (核閱報告) by PricewaterhouseCoopers, Taiwan, indicating it is a reviewed interim financial report. The report references compliance with International Accounting Standard 34 "Interim Financial Reporting" and includes detailed financial data and analysis for a period shorter than a full fiscal year (quarterly data). This matches the definition of an Interim / Quarterly Report (IR). The document is not a full annual report (10-K), nor is it merely an announcement or certification. It contains substantive financial statements and notes for the interim period. Therefore, the correct classification is IR with high confidence.
2024-11-11 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.